Drugmaker Pfizer said Wednesday it has begun a late-stage human trial of an influenza vaccine that uses the pioneering messenger-RNA deployed widely for the coronavirus.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer starts late-stage trial of mRNA-based flu vaccinePfizer Inc said on Wednesday it had started a late-stage U.S. trial of an influenza vaccine involving 25,000 patients, among the first such studies for a messenger RNA flu shot.
Lire la suite »
Harris County Public Health Has Pfizer Omicron Booster ShotsThe new COVID-19 vaccination booster shots are now available and Harris County Public Health began giving them out Monday. The bivalent Pfizer COVID-19 booster vaccine authorized for individuals 12 years and older, is available to eligible residents and is administered in a single dose. The new vaccine is designed to protect...
Lire la suite »
The Most Common Side Effects Of The New Bivalent COVID BoosterHere's what you can expect when you get the Pfizer or Moderna vaccine and how you can ease any symptoms.
Lire la suite »
EU watchdog approves vaccine targeting new Omicron sub-variantsEU's medicine watchdog approves vaccine specifically targeting the new and contagious BA.4 and BA.5 types of the Omicron variant amid fears of a new wave of Covid-19 winter infections
Lire la suite »